Powder vials
Store at −20 °C (−4 °F) in dry, dark conditions and keep them in the original packaging.

Elora is eloralintide, and unusually for this site, the numbers come straight out of a published phase 2 trial rather than from practice. It was given once weekly by subcutaneous injection at 1, 3, 6 or 9 mg, plus escalation arms, over 48 weeks. With a 10 mg vial mixed with 1 mL of water, 1 mg is 10 units on a U-100 syringe.
The amounts in this chart come from online communities. The vial label shows the total peptide in milligrams (mg). The Amount column shows a portion of that total in micrograms (mcg). The syringe mark shows how much liquid corresponds to that amount.
Syringe marks below are based on a 10 mg vial with 1 mL of water added. Change vial size or water in the calculator
| Reported | Amount | Volume | Syringe mark (U-100) | Draws per vial |
|---|
Convert your vial to mcg, because 1 mg is the same as 1,000 mcg.
Divide by your water to see how much is in 1 mL.
Find what one unit holds. A U-100 syringe has 100 units in 1 mL.
Divide your amount by what one unit holds.
Follow one step at a time. The steps use the water amount from your calculator.
Find the mg printed on your vial and enter it in the calculator. Let a frozen vial reach room temperature first.
Clean the top of the peptide vial and the water vial with an alcohol swab. Let them dry.
Draw bacteriostatic water with a sterile syringe.
Let the water run down the inside wall of the vial. This helps prevent foaming.
Roll the vial until the powder fully dissolves. Do not shake it hard.
Write today's date on the vial and refrigerate it at 2–8 °C (35.6–46.4 °F), away from light.

Pick how many weeks you will run it and how many shots you take each week. The list below shows everything you need.
Store at −20 °C (−4 °F) in dry, dark conditions and keep them in the original packaging.
Keep them refrigerated and away from light. How long a mixed vial lasts depends on the product, so check its stability data.
Eloralintide is a selective amylin receptor agonist. Amylin is a hormone released alongside insulin that signals fullness, and the interest in this class is that it works on a different pathway from the GLP-1 drugs.
Selective is the operative word. It targets the amylin receptor rather than hitting several receptors at once, which is the design difference people point to.
The trial endpoint was percentage change in bodyweight at 48 weeks, and that is the whole focus of the programme.
Amylin rather than GLP-1, which is why it gets discussed alongside and in combination with the GLP-1 drugs rather than as a copy of them.
The dosing interval comes from the molecule's duration, not from convenience.
The trial measured at 48 weeks. It was not built to tell you what happens in the first month.
A 48 week, multicentre, double blind, randomised, placebo controlled trial, published in The Lancet in November 2025. Around 263 participants were randomised across placebo, the four fixed doses and the escalation arms.
Weight reduction rose with dose across the range: roughly 9, 12, 18 and 20 percent at 1, 3, 6 and 9 mg, against about 0.4 percent on placebo. Figures vary slightly between the sponsor's reporting and the published rounding.
Nausea and fatigue were the most frequently reported adverse events. The sponsor's own presentation indicated escalation reduced them.
A protocol. A trial assigns a dose under supervision with a monitoring schedule attached. Reading the arms off a trial and running one is a different thing, and this is a compound with no approval behind it.

Quality varies a lot between sellers. I have been around research peptides for 10 years, and BioEdge is the supplier I send my readers to. Here is why.
The Peptide Report has a business relationship with BioEdge Research Labs. BioEdge sells this product for laboratory research only. BioEdge shipping policy
Pick a tool and try it. Each one uses the numbers from your calculator.
Use the same four steps. Once you can solve these, you can work out the units for any vial you ever pick up.
Your score: 0 correct.
Each line on the syringe is a unit of liquid. A unit measures volume, so the amount of peptide in it depends on your mix.
Tap the syringe or move the slider. The numbers use the vial you entered above. Read the line at the top edge of the plunger.
More water makes the mix weaker, so the same amount takes up more units. The amount of peptide in the vial stays the same.
A draw under 5 units is harder to read accurately. Tap a row to use that water amount.
The phase 2 trial used 1, 3, 6 or 9 mg once weekly by subcutaneous injection over 48 weeks, plus escalation arms. Those are trial assignments rather than a self-use protocol.
With a 10 mg vial and 1 mL of water, 1 mg is 10 units on a U-100 syringe, 3 mg is 30 units and 6 mg is 60 units. Use the calculator if your mix is different.
Yes. Eloralintide is the compound name. It also appears as LY3841136.
It works on the amylin receptor rather than the GLP-1 receptor. Different pathway, which is why the two get combined in research rather than substituted.
Roughly 9 percent at 1 mg up to about 20 percent at 9 mg over 48 weeks, against about 0.4 percent on placebo.
No. It is investigational, with phase 3 work reported to be underway.
Most charts assume one vial size and one water amount. If your mix is different, every unit number changes, so run your own numbers.
Instant e-Book Download